Clinical Trial Update: Leptin Signaling in Lean and Obese Humans

View source ↗

Summary

A clinical trial examining leptin signaling in lean and obese humans was withdrawn, with obesity listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: VA Office of Research and Development | Conditions: Obesity | Status: WITHDRAWN